share_log

中國天化工:股東特別大會通告

C ZENITH CHEM: NOTICE OF SPECIAL GENERAL MEETING

HKEX ·  Sep 9, 2024 19:57

Summary by Moomoo AI

中國天化工集團有限公司將於2024年9月24日下午四時三十分在香港中環舉行股東特別大會,以考慮通過與瑞邦證券有限公司訂立的配售協議。該協議涉及以每股0.1港元的價格配售最多6億股股份,並授權董事會根據協議條款行使配發及發行股份的一切權力。股東將於會上表決該普通決議案,並可委任代表出席及投票。股份過戶登記將於2024年9月19日至24日暫停,以確定有權出席會議的股東身份。
中國天化工集團有限公司將於2024年9月24日下午四時三十分在香港中環舉行股東特別大會,以考慮通過與瑞邦證券有限公司訂立的配售協議。該協議涉及以每股0.1港元的價格配售最多6億股股份,並授權董事會根據協議條款行使配發及發行股份的一切權力。股東將於會上表決該普通決議案,並可委任代表出席及投票。股份過戶登記將於2024年9月19日至24日暫停,以確定有權出席會議的股東身份。
c zenith chem Group Limited will hold a special general meeting of shareholders in Central, Hong Kong at 4:30 pm on September 24, 2024, to consider the approval of the placement agreement with Swissbond Securities Limited. The agreement involves the placement of up to 0.6 billion shares at a price of HK$0.1 per share, and authorizes the board of directors to exercise all powers to issue and distribute shares in accordance with the terms of the agreement. Shareholders will vote on the ordinary resolution at the meeting and may appoint representatives to attend and vote. Share transfer registration will be suspended from September 19 to 24, 2024, to verify the identity of shareholders who have the right to attend the meeting.
c zenith chem Group Limited will hold a special general meeting of shareholders in Central, Hong Kong at 4:30 pm on September 24, 2024, to consider the approval of the placement agreement with Swissbond Securities Limited. The agreement involves the placement of up to 0.6 billion shares at a price of HK$0.1 per share, and authorizes the board of directors to exercise all powers to issue and distribute shares in accordance with the terms of the agreement. Shareholders will vote on the ordinary resolution at the meeting and may appoint representatives to attend and vote. Share transfer registration will be suspended from September 19 to 24, 2024, to verify the identity of shareholders who have the right to attend the meeting.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more